Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Arcoma AB
  6. Summary
    ARCOMA   SE0006219176

ARCOMA AB

(ARCOMA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
12.3(c) 12.3(c) 12.35(c) 11.85(c) 12(c) Last
2 084 891 4 285 10 405 4 181 Volume
+2.50% 0.00% +0.41% -4.05% +1.27% Change
More quotes
Estimated financial data (e)
Sales 2021 132 M 14,4 M 14,4 M
Net income 2021 2,00 M 0,22 M 0,22 M
Net cash position 2021 6,00 M 0,66 M 0,66 M
P/E ratio 2021 85,7x
Yield 2021 -
Sales 2022 169 M 18,5 M 18,5 M
Net income 2022 9,00 M 0,98 M 0,98 M
Net cash position 2022 13,0 M 1,42 M 1,42 M
P/E ratio 2022 16,9x
Yield 2022 -
Capitalization 157 M 17,1 M 17,1 M
EV / Sales 2021 1,14x
EV / Sales 2022 0,85x
Nbr of Employees 32
Free-Float 53,7%
More Financials
Company
Arcoma AB is a Sweden-based medical technology company. It develops, produces and markets digital radiographic systems. Its products offer digital imaging technology combined with advanced mobile positioning system. The Company's product portfolio comprises: complete radiographic systems available as ceiling suspensions and floor mounted systems, as well as detectors; radiographic system components, such as overhead... 
More about the company
Ratings of Arcoma AB
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about ARCOMA AB
11/18Valberedning utsedd inför årsstämma 2022 i Arcoma AB
AQ
10/28Arcoma AB Reports Earnings Results for the Third Quarter and Nine Months Ended Septembe..
CI
08/25Arcoma AB Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
06/10ARCOMA : receives first order on the new product, OMNERA 500A
AQ
06/10Arcoma Receives First Order on the New Product, OMNERA 500A
CI
05/24Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
02/18Arcoma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
CI
2020ARCOMA : launches new X-ray system OMNERA 500A on the US market
AQ
2020Arcoma AB Launches Omnera 500A
CI
2020DELÅRSRAPPORT Q2 2020 : Stabil försäljning trots Covid-19. Stark lönsamhetsförbättring und..
GL
2020Kommuniké från årsstämma i Arcoma AB (publ)
GL
2020DELÅRSRAPPORT Q1 2020 : Starkt resultat i första kvartalet. EBITDA ökar med 169%.
GL
2020Konica Minolta Europa tecknar 5-årigt leverantörsavtal med Arcoma
GL
2020RÄTTELSE : Årsredovisning 2019 är nu publicerad
GL
2020Årsredovisning 2019 är nu publicerad
GL
More news
News in other languages on ARCOMA AB

- No features available -

More news
Chart ARCOMA AB
Duration : Period :
Arcoma AB Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 12,00 SEK
Average target price 21,00 SEK
Spread / Average Target 75,0%
EPS Revisions
Managers and Directors
Mattias Rundgren Chief Executive Officer & Business Controller
Lars Kvarnhem Chairman
Johan Henningsson Manager-Research & Development
Nicklas Johansson Operations Manager
Mats Johan Peter ThorÚn Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ARCOMA AB-45.45%17
SONOSCAPE MEDICAL CORP.17.09%1 909
BEIJING WANDONG MEDICAL TECHNOLOGY CO., LTD.124.21%1 907
NANO-X IMAGING LTD.-65.09%824
RAY CO., LTD.12.38%337
VIEWORKS CO., LTD.21.91%295